Voyager Therapeutics Inc (VYGR) Can’t Be More Risky. The Stock Formed a Bearish Multiple Bottom

September 17, 2017 - By Ellis Scott

The stock of Voyager Therapeutics Inc (VYGR) shows a multiple bottoms pattern with $14.88 target or 9.00 % below today’s $16.35 share price. The 7 months chart pattern indicates high risk for the $439.88 million company. It was reported on Sep, 17 by Finviz.com. If the $14.88 price target is reached, the company will be worth $39.59M less.
Multiple bottoms are very good trading chart patterns. These patterns have a low break even failure rate and decent average rise in a bull market, giving them a solid performance rank. Back-tests of such patterns show that the break even failure rate is 4%, the average rise: 37%, the throwback rate: 64% and the percentage of stocks meeting their price targets: 64%.

The stock increased 3.02% or $0.48 on September 15, reaching $16.35. About 553,881 shares traded or 101.39% up from the average. Voyager Therapeutics Inc (NASDAQ:VYGR) has declined 18.89% since September 17, 2016 and is downtrending. It has underperformed by 35.59% the S&P500.

Analysts await Voyager Therapeutics Inc (NASDAQ:VYGR) to report earnings on November, 9. They expect $-0.69 earnings per share, down 97.14 % or $0.34 from last year’s $-0.35 per share. After $-0.73 actual earnings per share reported by Voyager Therapeutics Inc for the previous quarter, Wall Street now forecasts -5.48 % EPS growth.

Voyager Therapeutics Inc (NASDAQ:VYGR) Ratings Coverage

Among 6 analysts covering Voyager Therapeutics (NASDAQ:VYGR), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Voyager Therapeutics had 7 analyst reports since December 7, 2015 according to SRatingsIntel. Chardan Capital Markets upgraded the stock to “Neutral” rating in Monday, January 25 report. Chardan Capital Markets initiated the stock with “Sell” rating in Wednesday, December 9 report. Cowen & Co initiated the shares of VYGR in report on Monday, December 7 with “Outperform” rating. As per Monday, December 7, the company rating was initiated by Piper Jaffray. The stock of Voyager Therapeutics Inc (NASDAQ:VYGR) earned “Outperform” rating by Wells Fargo on Friday, May 20. Stifel Nicolaus initiated the shares of VYGR in report on Friday, July 15 with “Buy” rating. Wedbush initiated the shares of VYGR in report on Monday, December 7 with “Outperform” rating.

More news for Voyager Therapeutics Inc (NASDAQ:VYGR) were recently published by: Globenewswire.com, which released: “Voyager Therapeutics Announces Positive Results from Ongoing Phase 1b Trial of …” on September 06, 2017. Nasdaq.com‘s article titled: “Voyager Therapeutics to Participate in September Investor Conferences” and published on August 30, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.